Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial (vol 15, 39, 2023)Bruno Dubois,Jesus Lopez-Arrieta,Stanley Lipschitz,Triantafyllos Doskas,Luiza Spiru,Svitlana Moroz,Olena Venger,Patrick Vermersch,Alain D. Moussy,Colin Mansfield,Olivier Hermine,Magda TsolakiALZHEIMERS RESEARCH & THERAPY（2023）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
